ARVN
NASDAQ · Pharmaceuticals
Arvinas Inc
$6.55
-0.87 (-11.73%)
Analyst Consensus
Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+911.0% upside
Low Target
$44.47
Average Target
$66.22
High Target
$75.30
Current Price
$6.55
Current
$6.55
$6.55
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Scenario Analysis
Bear Case
$44.47
578.9%
Low target
Base Case
$66.22
+911.0%
Avg target
Bull Case
$75.30
+1,049.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.51
-54.9% from high
52-Week Low
$6.52
+0.5% from low
Target vs 52W High
$66.22
+356.4% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.88
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals